1999
DOI: 10.1079/pns19990004
|View full text |Cite
|
Sign up to set email alerts
|

Isotopes in nutrition research

Abstract: The present lecture begins with a brief overview of the professional and scientific journey taken by Rudolf Schoenheimer, before turning to a discussion of the power of isotopic tracers in nutrition research. Schoenheimer's remarkable contributions to the study of intermediary metabolism and the turnover of body constituents, based initially on compounds tagged with 2H and later with 15N, spanned a mere decade. It is difficult, however, to overestimate the enormous impact of Schoenheimer's research on the evol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 134 publications
0
10
0
Order By: Relevance
“…The dominance of radioisotopes in metabolic and nutrition research continued through the 1970s, when stable isotopes began to supplant their use (Young and Ajami 1999). This shift was primarily driven by changing public awareness about the safety of radioisotopes, technological advances in mass spectrometry, and reduced costs of labeled tracers (Young and Ajami 1999); however, several other advantages of stable isotopes over radioisotopes are often cited: (a) Stable isotopes pose no significant health risks at tracer concentrations, (b) stable isotopes do not degrade over time and thus permit longterm experiments, (c) stable isotope tracers and tissue samples can be stored for extended periods, (d) several different stable isotope nuclides can be administered simultaneously, (e) stable isotope studies do not require approval by the Atomic Energy Commission, and (f) there are no special requirements for disposing of stable isotope waste.…”
Section: Stable Isotope Tracersmentioning
confidence: 99%
See 1 more Smart Citation
“…The dominance of radioisotopes in metabolic and nutrition research continued through the 1970s, when stable isotopes began to supplant their use (Young and Ajami 1999). This shift was primarily driven by changing public awareness about the safety of radioisotopes, technological advances in mass spectrometry, and reduced costs of labeled tracers (Young and Ajami 1999); however, several other advantages of stable isotopes over radioisotopes are often cited: (a) Stable isotopes pose no significant health risks at tracer concentrations, (b) stable isotopes do not degrade over time and thus permit longterm experiments, (c) stable isotope tracers and tissue samples can be stored for extended periods, (d) several different stable isotope nuclides can be administered simultaneously, (e) stable isotope studies do not require approval by the Atomic Energy Commission, and (f) there are no special requirements for disposing of stable isotope waste.…”
Section: Stable Isotope Tracersmentioning
confidence: 99%
“…The amount of "C in solid, liquid, and gaseous samples can be quantified using various mass spectrometric approaches (see reviews in Turnlund 1989, Bier 1997, Rennie 1999, Young and Ajami 1999. Gas chromatography-isotope ratio mass spectrometry (GC-IRMS) is one of the most popular approaches, and 2).…”
Section: Stable Isotope Tracersmentioning
confidence: 99%
“…Valuable accounts of Schoenheimer's career have been published by Kohler (12) and by Young and Ajami (13). He was born in Berlin in 1898 (12).…”
Section: Rudolf Schoenheimer and The Dynamic State Of Body Constituentsmentioning
confidence: 99%
“…This same enzyme takes on a 'moonlighting' role in biopterin cofactor regeneration, as stated earlier (p. 36), and therefore also becomes an important counter-regulatory effector for NO synthesis. Similarly, the normal role of CD26 is to serve as a T-helper 1 cell activation antigen and signal-binding site, while in its 'moonlighting' capacity as dipeptidyl peptidase IV it hydrolyzes chemokines and regulatory peptides, such as RANTES (regulated on activation, normal T-cell expressed and secreted) and glucagon-like peptide 1 respectively (Young & Ajami, 1999b). Function depends on whether the protein (enzyme) appears to act in its normal role or 'moonlighting' role and the 'moonlighting' aspects can be particularly instructive in understanding the natural history of pathophysiologies, which otherwise cannot be predicted by genomic potential alone.…”
Section: 'Catalytic Promiscuity' and 'Moonlighting Proteins'mentioning
confidence: 99%